DE3303083A1 - Immunologisches latex-agglutinationsverfahren und mittel - Google Patents

Immunologisches latex-agglutinationsverfahren und mittel

Info

Publication number
DE3303083A1
DE3303083A1 DE19833303083 DE3303083A DE3303083A1 DE 3303083 A1 DE3303083 A1 DE 3303083A1 DE 19833303083 DE19833303083 DE 19833303083 DE 3303083 A DE3303083 A DE 3303083A DE 3303083 A1 DE3303083 A1 DE 3303083A1
Authority
DE
Germany
Prior art keywords
latex
formula
agent
compound
latex agglutination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19833303083
Other languages
German (de)
English (en)
Inventor
Tibor Dipl.-Chem. Dr. 3550 Marburg Toth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Priority to DE19833303083 priority Critical patent/DE3303083A1/de
Priority to DE8484100793T priority patent/DE3463848D1/de
Priority to AT84100793T priority patent/ATE27366T1/de
Priority to EP84100793A priority patent/EP0117436B1/de
Priority to JP59013541A priority patent/JPS59151061A/ja
Priority to CA000446348A priority patent/CA1227751A/en
Priority to US06/575,403 priority patent/US4600698A/en
Priority to AU23932/84A priority patent/AU563471B2/en
Publication of DE3303083A1 publication Critical patent/DE3303083A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Peptides Or Proteins (AREA)
DE19833303083 1983-01-31 1983-01-31 Immunologisches latex-agglutinationsverfahren und mittel Withdrawn DE3303083A1 (de)

Priority Applications (8)

Application Number Priority Date Filing Date Title
DE19833303083 DE3303083A1 (de) 1983-01-31 1983-01-31 Immunologisches latex-agglutinationsverfahren und mittel
DE8484100793T DE3463848D1 (en) 1983-01-31 1984-01-26 Immunological latex agglutination method
AT84100793T ATE27366T1 (de) 1983-01-31 1984-01-26 Immunologisches latex-agglutinationsverfahren.
EP84100793A EP0117436B1 (de) 1983-01-31 1984-01-26 Immunologisches Latex-Agglutinationsverfahren
JP59013541A JPS59151061A (ja) 1983-01-31 1984-01-30 免疫学的ラテツクス凝集法
CA000446348A CA1227751A (en) 1983-01-31 1984-01-30 Procedure and agent for immunological latex agglutination
US06/575,403 US4600698A (en) 1983-01-31 1984-01-30 Immunological latex agglutination in presence of certain lactones or lactams
AU23932/84A AU563471B2 (en) 1983-01-31 1984-01-31 Procedure and agent for immunological latex agglutination

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833303083 DE3303083A1 (de) 1983-01-31 1983-01-31 Immunologisches latex-agglutinationsverfahren und mittel

Publications (1)

Publication Number Publication Date
DE3303083A1 true DE3303083A1 (de) 1984-08-02

Family

ID=6189610

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19833303083 Withdrawn DE3303083A1 (de) 1983-01-31 1983-01-31 Immunologisches latex-agglutinationsverfahren und mittel
DE8484100793T Expired DE3463848D1 (en) 1983-01-31 1984-01-26 Immunological latex agglutination method

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE8484100793T Expired DE3463848D1 (en) 1983-01-31 1984-01-26 Immunological latex agglutination method

Country Status (7)

Country Link
US (1) US4600698A (https=)
EP (1) EP0117436B1 (https=)
JP (1) JPS59151061A (https=)
AT (1) ATE27366T1 (https=)
AU (1) AU563471B2 (https=)
CA (1) CA1227751A (https=)
DE (2) DE3303083A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0661541A3 (de) * 1993-12-29 1996-01-31 Behringwerke Ag Verfahren zur Herstellung langzeitstabiler klarer Seren.
WO2020221917A1 (en) * 2019-05-01 2020-11-05 Novochem Green Additives B.V. Eutectic composition

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695537A (en) * 1982-05-21 1987-09-22 The University Of Tennessee Research Corp. Particles sensitized with detergent-treated antigen for agglutination immunoassay
US4921787A (en) * 1987-05-01 1990-05-01 Cambridge Bioscience Corporation Detection of antibodies to human immunodeficiency virus by agglutination of antigen coated latex
DE3725475A1 (de) * 1987-07-31 1989-02-09 Boehringer Mannheim Gmbh Verfahren zur beseitigung von unspezifischen truebungen
US4847209A (en) * 1987-11-09 1989-07-11 Miles Inc. Latex agglutination immunoassay in the presence of hemoglobin
US5175112A (en) * 1989-01-20 1992-12-29 Diagnostica Stago Submicron particles, preparation and utilization in immunodiagnosis
DE4202923A1 (de) * 1992-02-01 1993-08-05 Behringwerke Ag Verfahren zur bestimmung von antigenen oder antikoerpern in gegenwart eines immunkomplexes
DE4202924A1 (de) * 1992-02-01 1993-08-05 Behringwerke Ag Verfahren zur bestimmung von rheumafaktoren und mittel zur durchfuehrung des verfahrens
JPH06265551A (ja) * 1993-03-11 1994-09-22 Hoechst Japan Ltd ゼータ電位を用いた免疫学的測定方法及び免疫学的測定用キット
EP3690441B1 (en) * 2017-09-29 2023-05-10 Sekisui Medical Co., Ltd. Method for reducing measurement error in latex immunoagglutination assay

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5443572B2 (https=) * 1974-07-08 1979-12-20
US4003988A (en) * 1976-06-01 1977-01-18 Warner-Lambert Company Direct agglutination test for pregnancy
US4208187A (en) * 1977-12-19 1980-06-17 American Home Products Corporation Diagnostic test
JPS5530655A (en) * 1978-08-28 1980-03-04 Seikagaku Kogyo Co Ltd Latex sensitive to human igg antibody for quantitizing human igg and its particle composite
JPS5933228B2 (ja) * 1978-12-25 1984-08-14 武田薬品工業株式会社 妊娠診断反応用被検液の前処理方法ならびに前処理剤
IL56342A (en) * 1978-12-29 1982-05-31 Zer Tamar Method and means for determining human chorionic gonadotropin in urine
CA1146852A (en) * 1979-01-31 1983-05-24 Koichi Kondo Reagent for latex agglutination
AU543007B2 (en) * 1980-04-15 1985-03-28 Technicon Instruments Corportion Agglutination immunoassay

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0661541A3 (de) * 1993-12-29 1996-01-31 Behringwerke Ag Verfahren zur Herstellung langzeitstabiler klarer Seren.
US5714333A (en) * 1993-12-29 1998-02-03 Behring Diagnostics Gmbh Process for preparing clear sera which are stable over a long period
WO2020221917A1 (en) * 2019-05-01 2020-11-05 Novochem Green Additives B.V. Eutectic composition

Also Published As

Publication number Publication date
JPS59151061A (ja) 1984-08-29
ATE27366T1 (de) 1987-06-15
CA1227751A (en) 1987-10-06
US4600698A (en) 1986-07-15
JPH0426062B2 (https=) 1992-05-06
DE3463848D1 (en) 1987-06-25
AU2393284A (en) 1984-08-02
EP0117436A1 (de) 1984-09-05
AU563471B2 (en) 1987-07-09
EP0117436B1 (de) 1987-05-20

Similar Documents

Publication Publication Date Title
DE2705897C3 (de) Verfahren zur radioimmunologischen Bestimmung von cyclischem Adenosin-3', 5'-monophosphat und/oder cyclischem Guanosin-3'3'-monophosphat
DE2849708C2 (https=)
DE68918166T2 (de) Spezifische Bindungszusammensetzung mit einem Protein oder einem Kohlenhydrat mit Nieder-pI und ein diagnostischer Testsatz und Verfahren zur Anwendung.
DE3002973C2 (https=)
DE2653032C2 (de) Radioimmunoassay für ein Schilddrüsenhormon und Reagenz zu dessen Durchführung
EP0001224A1 (de) Verfahren zur Herstellung eines wasserunlöslichen, immunologisch-diagnostischen Reagenzes
DE69329998T2 (de) Bestimmung von estradiol durch kompetitiven immunoassay
EP0117436B1 (de) Immunologisches Latex-Agglutinationsverfahren
EP0035211B1 (de) Verfahren und Reagens zur Bestimmung der beta-Lipoproteine (LDL)
EP0957360B1 (de) Entstörung durch Rheumafaktoren
DE69527977T2 (de) Stabile wässrige Steroid-Standardproben für Immuntests
DE3877032T2 (de) Diagnostischer immunoassay fuer digoxin mit festphasetrennung.
DE2827250C2 (de) Latexreagenz aus einem mit Steroid- Serumalbumin-Konjugat sensibilisierten Polymerlatex und Verfahren zur Herstellung dieses Latexreagenz
DE2023989C3 (de) Verfahren zur Herstellung von aus Antigen-Trägerstoffgemischen bestehenden und gegebenenfalls Antikörper enthaltenden fertigen serodiagnostischen, auf einen Objektträger aufgebrachten lagerbeständigen Testsubstanzen
DE69025008T2 (de) Verfahren für direkte chemische Bindung des D-Dimers aus einer biologischen Probe zwecks Diagnostik und Überwachung von thrombolytischen und hyperkoagulablen Zuständen
DE1598928A1 (de) Verfahren zum Nachweis der infektioesen Mononukleose und Nachweisreagenz
EP0017909B1 (de) Verfahren zur Bestimmung von Anti-Hyaluronidase und hierfür verwendbares Mittel
DE2431255C3 (de) Amino-alkyläther des Morphins, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung eines Reagens zur antikörperspezifischen Bestimmung von Opiumalkaloiden
DE3781841T2 (de) Diagnostisches immuntest-verfahren mittels festphasenabscheidung.
DE2537275A1 (de) Immunchemisches verfahren zur bestimmung von antigenen und antikoerpern in biologischen fluessigkeiten
DE3637253A1 (de) Latex-agglutinations-verfahren zum nachweis von anti-streptokokken-desoxyribonuclease b
EP0554657A2 (de) Verfahren zur Bestimmung von Antigenen oder Antikörpern in Gegenwart eines Immunkomplexes
EP0332021B1 (de) Mittel für immunchemische Tests enthaltend Aminoxide
EP0583689B1 (de) Immunchemisches Verfahren zum Nachweis eines Analyten
EP0290017B1 (de) Verfahren zur quantitativen Bestimmung von Serumproteinen in Körperflüssigkeiten und Mittel zur Durchführung des Verfahrens

Legal Events

Date Code Title Description
8141 Disposal/no request for examination